Soft Tissue Neoplasms
9
0
0
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
11.1%
1 terminated out of 9 trials
83.3%
-3.2% vs benchmark
0%
0 trials in Phase 3/4
40%
2 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (9)
Study of MEK162 for Children With Low-Grade Gliomas
Investigation Into the Safety and Efficacy of ICG-Labeled Fluorescence Imaging Technology in Guiding the Resection of Bone and Soft Tissue Tumors
Ewing Sarcoma Family of Tumors (ESFT): A 15-year Experience From a Tertiary Care Cancer Center in Upper Egypt
Malignant Pediatric Soft Tissue & Bone Tumors of the Extremities: A Retrospective Study
Feasibility of ExAblate MRI Guided High Intensity Focused Ultrasound Tx of Soft Tissue Tumors
Treatment Response Evaluation in Gastrointestinal Stromal Tumor (GIST) Patients
Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics
Radiofrequency Ablation of Painful Soft Tissue Neoplasms
Clinical Outcome of Pediatric Dermatofibrosarcoma Protuberans